Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation
- 1 March 2004
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 23 (3), 277-283
- https://doi.org/10.1016/s1053-2498(03)00148-7
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Inflammation and AtherosclerosisCirculation, 2002
- Viral Triggers of Cardiac-Allograft DysfunctionNew England Journal of Medicine, 2001
- Association of Viral Genome with Graft Loss in Children after Cardiac TransplantationNew England Journal of Medicine, 2001
- Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitisAnnals Of The Rheumatic Diseases, 2001
- The Possible Role of Hepatitis A Virus in the Pathogenesis of AtherosclerosisThe Journal of Infectious Diseases, 2000
- Outcome of De Novo hepatitis C virus infection in heart transplant recipientsHepatology, 1999
- Predictive model to assess risk for cardiac allograft vasculopathy: An intravascular ultrasound studyJournal of the American College of Cardiology, 1995
- A Role for Hepatitis C Virus Infection in Type II CryoglobulinemiaNew England Journal of Medicine, 1992
- Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery diseasePublished by American Medical Association (AMA) ,1992
- Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosisJAMA, 1989